Effectiveness of The Health Care CEO App for T1D - Trial NCT05022875
Access comprehensive clinical trial information for NCT05022875 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung University and is currently Recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 96 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung University
Timeline & Enrollment
N/A
Apr 23, 2021
Jul 31, 2022
Primary Outcome
Change in HbA1c,Change in % with HbA1c 7.0%,Change in Hyperglycemic Events,Change in Hypoglycemic Events
Summary
The present study aims to evaluate the intervention effectiveness of the Healthcare Chief
 Executive Officer mobile application(Healthcare CEO app) in patients with type 1 diabetes
 transitioning from adolescence to early adulthood.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05022875
Device Trial